Osman Younus1, Umaima Mulla1. 1. Department of Ophthalmology, University Hospital Hairmyres, Glasgow, UK.
Abstract
PURPOSE: To report a case of posterior scleritis following COVID-19 vaccination. STUDY DESIGN: Case report. RESULTS: A 78-year-old female presented with headache and right-sided visual loss 10 days after the second dose of COVID-19 vaccine. 'Examination showed disc oedema and a serous retinal detachment. B-scan ultrasound showed thickening of the posterior sclera with retroscleral fluid. CT head with venogram excluded venous sinus thrombosis. The patient's condition improved rapidly with oral corticosteroids with restoration of vision and resolution of disc swelling and serous detachment by 4 weeks. CONCLUSIONS: Posterior scleritis should be considered in patients presenting with headaches and blurred vision following vaccination. Timely diagnosis and treatment with corticosteroids can prevent permanent visual loss.
PURPOSE: To report a case of posterior scleritis following COVID-19 vaccination. STUDY DESIGN: Case report. RESULTS: A 78-year-old female presented with headache and right-sided visual loss 10 days after the second dose of COVID-19 vaccine. 'Examination showed disc oedema and a serous retinal detachment. B-scan ultrasound showed thickening of the posterior sclera with retroscleral fluid. CT head with venogram excluded venous sinus thrombosis. The patient's condition improved rapidly with oral corticosteroids with restoration of vision and resolution of disc swelling and serous detachment by 4 weeks. CONCLUSIONS: Posterior scleritis should be considered in patients presenting with headaches and blurred vision following vaccination. Timely diagnosis and treatment with corticosteroids can prevent permanent visual loss.
Entities:
Keywords:
COVID-19; COVID-19 vaccination; Case report; posterior scleritis